Correlational analyses were additionally performed using 18F-AV1451 binding in the midbrain, frontal lobe, and global cortical level to assess whether these PSP-prone regions in terms of tau pathology had specific structural impairment related to their 18F-AV1451 binding. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.